title: Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.
abstract: BACKGROUND
  Annexin A1 (ANXA1) is a protein related with the carcinogenesis process and metastasis formation in many tumors. However, little is known about the prognostic value of ANXA1 in breast cancer. The purpose of this study is to evaluate the association between ANXA1 expression, BRCA1/2 germline carriership, specific tumor subtypes and survival in breast cancer patients.
  
  
  METHODS
  Clinical-pathological information and follow-up data were collected from nine breast cancer studies from the Breast Cancer Association Consortium (BCAC) (n = 5,752) and from one study of familial breast cancer patients with BRCA1/2 mutations (n = 107). ANXA1 expression was scored based on the percentage of immunohistochemical staining in tumor cells. Survival analyses were performed using a multivariable Cox model.
  
  
  RESULTS
  The frequency of ANXA1 positive tumors was higher in familial breast cancer patients with BRCA1/2 mutations than in BCAC patients, with 48.6 % versus 12.4 %, respectively; P <0.0001. ANXA1 was also highly expressed in BCAC tumors that were poorly differentiated, triple negative, EGFR-CK5/6 positive or had developed in patients at a young age. In the first 5 years of follow-up, patients with ANXA1 positive tumors had a worse breast cancer-specific survival (BCSS) than ANXA1 negative (HRadj = 1.35; 95 % CI = 1.05-1.73), but the association weakened after 10 years (HRadj = 1.13; 95 % CI = 0.91-1.40). ANXA1 was a significant independent predictor of survival in HER2+ patients (10-years BCSS: HRadj = 1.70; 95 % CI = 1.17-2.45).
  
  
  CONCLUSIONS
  ANXA1 is overexpressed in familial breast cancer patients with BRCA1/2 mutations and correlated with poor prognosis features: triple negative and poorly differentiated tumors. ANXA1 might be a biomarker candidate for breast cancer survival prediction in high risk groups such as HER2+ cases.
authors.affiliation: Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. m.leite@nki.nl.|Programa de Farmacologia, Instituto Nacional do Câncer (INCA), Rio de Janeiro, RJ, Brazil. m.leite@nki.nl.
authors.forename: Marcelo
authors.initials: M
authors.lastname: Sobral-Leite
authors.affiliation: Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. j.wesseling@nki.nl.|Division of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. j.wesseling@nki.nl.
authors.forename: Jelle
authors.initials: J
authors.lastname: Wesseling
authors.affiliation: Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. V.T.H.B.M.Smit@lumc.nl.
authors.forename: Vincent T H B M
authors.initials: VT
authors.lastname: Smit
authors.affiliation: University of Helsinki, Helsinki, Finland. Heli.Nevanlinna@hus.fi.|Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. Heli.Nevanlinna@hus.fi.
authors.forename: Heli
authors.initials: H
authors.lastname: Nevanlinna
authors.affiliation: Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. m.v.miltenburg@nki.nl.
authors.forename: Martine H
authors.initials: MH
authors.lastname: van Miltenburg
authors.affiliation: Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. jo.sanders@nki.nl.
authors.forename: Joyce
authors.initials: J
authors.lastname: Sanders
authors.affiliation: Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. i.hofland@nki.nl.
authors.forename: Ingrid
authors.initials: I
authors.lastname: Hofland
authors.affiliation: Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. fmb28@medschl.cam.ac.uk.
authors.forename: Fiona M
authors.initials: FM
authors.lastname: Blows
authors.affiliation: Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. Penny.Coulson@icr.ac.uk.
authors.forename: Penny
authors.initials: P
authors.lastname: Coulson
authors.affiliation: Breakthrough Breast Cancer Centre, London, UK. patrycja.gazinska@kcl.ac.uk.
authors.forename: Gazinska
authors.initials: G
authors.lastname: Patrycja
authors.affiliation: Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. j.schellens@nki.nl.|Department of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands. j.schellens@nki.nl.
authors.forename: Jan H M
authors.initials: JH
authors.lastname: Schellens
authors.affiliation: University of Helsinki, Helsinki, Finland. rainer.fagerholm@helsinki.fi.|Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. rainer.fagerholm@helsinki.fi.
authors.forename: Rainer
authors.initials: R
authors.lastname: Fagerholm
authors.affiliation: University of Helsinki, Helsinki, Finland. paivi.heikkila@hus.fi.|Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland. paivi.heikkila@hus.fi.
authors.forename: Päivi
authors.initials: P
authors.lastname: Heikkilä
authors.affiliation: University of Helsinki, Helsinki, Finland. kristiina.aittomaki@helsinki.fi.|Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland. kristiina.aittomaki@helsinki.fi.
authors.forename: Kristiina
authors.initials: K
authors.lastname: Aittomäki
authors.affiliation: University of Helsinki, Helsinki, Finland. carl.blomqvist@helsinki.fi.|Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. carl.blomqvist@helsinki.fi.
authors.forename: Carl
authors.initials: C
authors.lastname: Blomqvist
authors.affiliation: Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge, UK. elena.provenzano@addenbrookes.nhs.uk.|Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK. elena.provenzano@addenbrookes.nhs.uk.
authors.forename: Elena
authors.initials: E
authors.lastname: Provenzano
authors.affiliation: Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge, UK. Raza.Ali@cruk.cam.ac.uk.|Department of Pathology, University of Cambridge, Cambridge, UK. Raza.Ali@cruk.cam.ac.uk.
authors.forename: Hamid Raza
authors.initials: HR
authors.lastname: Ali
authors.affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. figueroaj@mail.nih.gov.
authors.forename: Jonine
authors.initials: J
authors.lastname: Figueroa
authors.affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. shermanm@exchange.nih.gov.|Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA. shermanm@exchange.nih.gov.
authors.forename: Mark
authors.initials: M
authors.lastname: Sherman
authors.affiliation: Department of Cancer Epidemiology and Prevention, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. lissowsj@coi.waw.pl.
authors.forename: Jolanta
authors.initials: J
authors.lastname: Lissowska
authors.affiliation: School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. arto.mannermaa@uef.fi.|Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. arto.mannermaa@uef.fi.|Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. arto.mannermaa@uef.fi.
authors.forename: Arto
authors.initials: A
authors.lastname: Mannermaa
authors.affiliation: Cancer Center, Kuopio University Hospital, Kuopio, Finland. vesa.kataja@ksshp.fi.|Jyväskylä Central Hospital, Jyväskylä, Finland. vesa.kataja@ksshp.fi.
authors.forename: Vesa
authors.initials: V
authors.lastname: Kataja
authors.affiliation: School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. veli-matti.kosma@uef.fi.|Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. veli-matti.kosma@uef.fi.|Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. veli-matti.kosma@uef.fi.
authors.forename: Veli-Matti
authors.initials: VM
authors.lastname: Kosma
authors.affiliation: School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. jaana.hartikainen@uef.fi.|Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. jaana.hartikainen@uef.fi.|Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. jaana.hartikainen@uef.fi.
authors.forename: Jaana M
authors.initials: JM
authors.lastname: Hartikainen
authors.affiliation: Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. Kelly.Phillips@petermac.org.|Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. Kelly.Phillips@petermac.org.|Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, The University of Melbourne, Melbourne, Australia. Kelly.Phillips@petermac.org.|Department of Medicine, St Vincent's Hospital, The University of Melbourne, Melbourne, Australia. Kelly.Phillips@petermac.org.
authors.forename: Kelly-Anne
authors.initials: KA
authors.lastname: Phillips
authors.affiliation: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. couch.fergus@mayo.edu.
authors.forename: Fergus J
authors.initials: FJ
authors.lastname: Couch
authors.affiliation: Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. olsonj@mayo.edu.
authors.forename: Janet E
authors.initials: JE
authors.lastname: Olson
authors.affiliation: Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. vachon.celine@mayo.edu.
authors.forename: Celine
authors.initials: C
authors.lastname: Vachon
authors.affiliation: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. visscher.daniel@mayo.edu.
authors.forename: Daniel
authors.initials: D
authors.lastname: Visscher
authors.affiliation: Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. h.brenner@dkfz.de.|German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. h.brenner@dkfz.de.|Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. h.brenner@dkfz.de.
authors.forename: Hermann
authors.initials: H
authors.lastname: Brenner
authors.affiliation: Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. k.butterbach@dkfz.de.
authors.forename: Katja
authors.initials: K
authors.lastname: Butterbach
authors.affiliation: Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. v.arndt@dkfz.de.
authors.forename: Volker
authors.initials: V
authors.lastname: Arndt
authors.affiliation: Saarland Cancer Registry, Saarbrücken, Germany. B.Holleczek@gbe-ekr.saarland.de.
authors.forename: Bernd
authors.initials: B
authors.lastname: Holleczek
authors.affiliation: Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. m.hooning@erasmusmc.nl.
authors.forename: Maartje J
authors.initials: MJ
authors.lastname: Hooning
authors.affiliation: Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. a.hollestelle@erasmusmc.nl.
authors.forename: Antoinette
authors.initials: A
authors.lastname: Hollestelle
authors.affiliation: Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. j.martens@erasmusmc.nl.
authors.forename: John W M
authors.initials: JW
authors.lastname: Martens
authors.affiliation: Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. c.h.m.vandeurzen@erasmusmc.nl.
authors.forename: Carolien H M
authors.initials: CH
authors.lastname: van Deurzen
authors.affiliation: Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. b.water@lacdr.leidenuniv.nl.
authors.forename: Bob
authors.initials: B
authors.lastname: van de Water
authors.affiliation: Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. a.broeks@nki.nl.
authors.forename: Annegien
authors.initials: A
authors.lastname: Broeks
authors.affiliation: Division of Cancer Epidemiology, Unit of Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. j.chang-claude@dkfz-heidelberg.de.
authors.forename: Jenny
authors.initials: J
authors.lastname: Chang-Claude
authors.affiliation: Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. Georgia.Trench@qimrberghofer.edu.au.
authors.forename: Georgia
authors.initials: G
authors.lastname: Chenevix-Trench
authors.affiliation: Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. dfe20@medschl.cam.ac.uk.
authors.forename: Douglas F
authors.initials: DF
authors.lastname: Easton
authors.affiliation: Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. paul.pharoah@srl.cam.ac.uk.
authors.forename: Paul D P
authors.initials: PD
authors.lastname: Pharoah
authors.affiliation: Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. Montse.GarciaClosas@icr.ac.uk.|Breakthrough Breast Cancer Centre, London, UK. Montse.GarciaClosas@icr.ac.uk.
authors.forename: Montserrat
authors.initials: M
authors.lastname: García-Closas
authors.affiliation: Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. m.de.graauw@lacdr.leidenuniv.nl.
authors.forename: Marjo
authors.initials: M
authors.lastname: de Graauw
authors.affiliation: Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. mk.schmidt@nki.nl.|Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. mk.schmidt@nki.nl.
authors.forename: Marjanka K
authors.initials: MK
authors.lastname: Schmidt
mesh_terms: D000328:Adult; D017305:Annexin A1 / Q000235:genetics*; D014408:Biomarkers, Tumor / Q000235:genetics; D001943:Breast Neoplasms / Q000175:diagnosis / Q000235:genetics; D005260:Female; D019398:Genes, BRCA1 / Q000502:physiology; D024522:Genes, BRCA2 / Q000502:physiology; D020022:Genetic Predisposition to Disease; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D009154:Mutation; D011379:Prognosis
chemical_list: D017305:Annexin A1; D014408:Biomarkers, Tumor